Dacron or PTFE for Above-knee Femoropopliteal Bypass. A Multicenter Randomised Study

European Journal of Vascular and Endovascular Surgery

Volumn 34, Issue 1, 2007, Pages 44-49

  Jensen, L P ^a   Lepantalo M ^b   Fossdal, J E ^c   Roder O C ^d   Jensen, B S ^e   Madsen, M S ^f   Grenager, O ^g   Fasting, H ^h   Myhre, H O ⁱ   Baekgaard N ^a   Nielsen, O M ^a   Helgstrand, U ^j   Schroeder, T V ^j  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c Stavanger Universitetssykehus ^*  (Norway)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

^f KOLDING HOSPITAL   (Denmark)

^g AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^h VIBORG HOSPITAL   (Denmark)

ⁱ TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^j Rigshospitalet   (Denmark)

more..

Author keywords

Above knee; Claudication; Critical ischemia; Dacron; Femoro popliteal bypass; Peripheral bypass; PTFE

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; DACRON; POLITEF;

ADULT; AGE; AGED; ANKLE BRACHIAL INDEX; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENMARK; DIABETES MELLITUS; FEMALE; FEMOROPOPLITEAL BYPASS; FINLAND; FOLLOW UP; GENDER; HUMAN; HYPERTENSION; INTERMITTENT CLAUDICATION; LEG ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; NORWAY; OUTCOME ASSESSMENT; POLITEF IMPLANT; POSTOPERATIVE INFECTION; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; TREATMENT INDICATION; VASCULAR PATENCY; WOUND INFECTION;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGRAPHY; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; FEMALE; FEMORAL ARTERY; FOLLOW-UP STUDIES; HUMANS; ISCHEMIA; LEG; MALE; MIDDLE AGED; POLYETHYLENE TEREPHTHALATES; POLYTETRAFLUOROETHYLENE; POPLITEAL ARTERY; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 34249867722     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2007.01.016     Document Type: Article

References (13)

1. Veith F.J., Gupta S.K., Ascer E., White-Flores S., Samson R.H., Scher L.A., et al. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg 3 (1986) 104-114
2. Faries P.L., LoGerfo F.W., Arora S., Hook S., Pulling M.C., Akbari C.M., et al. A comparative study of alternative conduits for lower extremity revascularization: all-autogenous conduit versus prosthetic grafts. J Vasc Surg 32 (2000) 1080-1090
3. Klinkert P., Post P.N., Breslau P.J., and van Bockel J.H. Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature. Eur J Vasc Endovasc Surg 27 (2004) 357-362
4. Carlos Eduardo Pereira C.E., Albers M., Romiti M., Francisco C.B.N., and Pereira C.A.B. Meta-analysis of femoropopliteal bypass grafts for lower extremity arterial insufficiency. J Vasc Surg 44 (2006) 510-517
5. Sterpetti A.V., Schultz R.D., Feldhaus R.J., and Peetz D.J. Seven-year experience with polytetrafluoroethylene as above-knee femoropopliteal bypass graft. Is it worthwhile to preserve the autologous saphenous vein?. J Vasc Surg 2 (1985) 907-912
6. Abbott W.M., Green R.M., Matsumoto T., Wheeler J.R., Miller N., Veith F.J., et al. Prosthetic above-knee femoropopliteal bypass grafting: results of a multicenter randomized prospective trial. Above-Knee Femoropopliteal Study Group. J Vasc Surg 25 (1997) 19-28
7. Green R.M., Abbott W.M., Matsumoto T., Wheeler J.R., Miller N., Veith F.J., et al. Prosthetic above-knee femoropopliteal bypass grafting: five-year results of a randomized trial. J Vasc Surg 31 (2000) 417-425
8. Robinson B.I., Fletcher J.P., Tomlinson P., Allen R.D.M., Hazelton S.J., Richardson A.J., et al. A Prospective randomized multicentre comparison of expanded polytetrafluoroethylene and gelatin-sealed knitted Dacron grafts for femoropopliteal bypass. Cardiovasc Surg 7 (1999) 214-218
9. Post S., Kraus T., Müller-Reinartz U., Weiß C., Kortmann H., Quentmeier A., et al. Dacron vs polytetrafluoroethylene grafts for femoropopliteal bypass: a prospective randomised multicentre trial. Eur J Vasc Endovasc Surg 22 (2001) 226-231
10. Devine C., Hons B.A., and McCollum C. Heparin-bonded Dacron or polytetrafluoroethylene for femoropopliteal bypass: five-year results of a prospective randomized multicenter clinical trial. J Vasc Surg 40 (2004) 924-931
11. Robinson B.I., Fletcher J.P., and the Australian and New Zealand Femoropopliteal Graft Trial Participants. Fluoropolymer coated Dacron or polytetrafluoroethylene for femoropopliteal bypass grafting: a multicentre trial. ANZ J Surg 73 (2003) 95-99
12. Mamode N., and Scott R.N. Graft type for femoro-popliteal bypass surgery. Cochrane Database Syst Rev (1999) 10.1002/14651858.CD001487 (Issue 2. Art. No.: CD001487)
13. Bosiers M., Deloose K., Verbist J., Schroë H., Lauwers G., Lansink W., et al. Heparin-bonded expanded polytetrafluoroethylene vascular graft for femoropopliteal and femorocrural bypass grafting: 1 year results. J Vasc Surg 43 (2006) 313-319